BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Myconostica Ltds MycAssay(TM) Aspergillus Test to Improve Diagnosis of Aspergillus Bronchitis in Patients with Cystic Fibrosis

  December 6, 2010

   · 

  3 min read
• Business

  RIKEN Chooses Helicos BioSciences Corporation Single Molecule Sequencing for Global Map of Human Promoters

  December 6, 2010

   · 

  2 min read
• Microbix Biosystems Inc. Completes $600,250 Private Placement

  December 6, 2010

   · 

  1 min read
• BioMidwest

  World Health Organization Announces Levacor VAD Could Avoid Key Problem Associated With Current VAD Treatment

  December 6, 2010

   · 

  4 min read
• Pharm Country

  St. Jude Medical Neurostimulation Study Shows 70% Of Patients Report Pain Relief

  December 6, 2010

   · 

  1 min read
• Drug Development

  Celgene International Sárl Release: New Clinical Data Evaluating ISTODAX(R) in Pivotal Open-Label Phase II Study for Patients with Peripheral T-Cell Lymphoma (PTCL)

  December 6, 2010

   · 

  1 min read
• Pharm Country

  EpiCept Corporation Announces Ceplene(R) Poster Presentation at the 52nd Annual Meeting of the American Society of Hematology

  December 6, 2010

   · 

  1 min read
• Drug Development

  Aoxing Pharmaceutical Company Inc. Initiates Registration Clinical Trial of Buprenorphine / Naloxone Sublingual Tablets for Opioid Addiction Treatment

  December 6, 2010

   · 

  3 min read
• Drug Development

  Incyte Corporation Presents Positive Long-Term Results from Ongoing Phase II Trial of INCB18424 in Advanced Polycythemia Vera (PV) and Essential Thrombocythemia (ET) at the American Society of Hematology Annual Meeting

  December 6, 2010

   · 

  1 min read
• Biotech Bay

  StemCells Inc. Expands SC Proven(R) Product Portfolio With Launch of Proprietary Human Cell Detection Antibodies

  December 6, 2010

   · 

  1 min read